ClinicalTrials.Veeva

Menu

Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand

T

Thai Red Cross AIDS Research Centre

Status

Completed

Conditions

Men Who Have Sex With Men and Transgender Women

Study type

Observational

Funder types

Other

Identifiers

NCT03580512
POC HIV&STI

Details and patient eligibility

About

This will be a prospective study that will enroll up to 2000 MSM and TG from community-based clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.

Full description

Eligible participants will be followed up until the completion of a 12-month period. All participants will be followed up every 3 months. An additional follow up visit at month 1 will be made for participants who PrEP is initiated at entry visit (those who already received PrEP prior to the study will not need the additional visit).

Study Sites

The study will take place at the following community-based clinics:

  1. SWING DIC, Bangkok, Thailand
  2. RSAT DIC, Bangkok, Thailand
  3. SWING DIC, Chonburi, Thailand
  4. Sisters DIC, Chonburi, Thailand
  5. Mplus DIC, Chiang Mai, Thailand
  6. RSAT DIC, Songkhla, Thailand

Enrollment

2,000 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Thai nationality

  2. Age ≥ 18 years old

  3. Men or transgender women who have sex with men

  4. Have at least one of the following risks for HIV acquisition in the past 6 months:

    • Any unprotected receptive anal sex
    • More than 5 sexual partners, regardless of condom use and serostatus
    • History of syphilis, chlamydia or gonorrhea diagnosed or treated
    • Any stimulant drug use
  5. Have signed the consent form

Exclusion criteria

  • None

Trial design

2,000 participants in 3 patient groups

Group 1
Description:
- 800 existing clients who already received PrEP
Group 2
Description:
* 800 new clients who present for HIV testing and are HIV-negative. All will be offered PrEP * 600 clients who will refuse PrEP * 200 clients who will receive PrEP
Group 3
Description:
- 400 new clients who are HIV-positive or new clients who present for HIV testing and are HIV-positive

Trial contacts and locations

6

Loading...

Central trial contact

Nittaya Phanuphak, M.D., Ph.D.; Reshmie Ramautarsing, M.D.,Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems